LTRN ▼ -1.0% - Lantern Pharma Inc.
$LTRN - Lantern Pharma Receives Taiwan Approvals to Open Next Stage of Phase 2 HARMONIC™ Trial of LP-300 in Never-Smoker, EGFR-Mutant NSCLC
07-OCT-2026 08:41 AM ET
Share this post
More filings for $LTRN
LTRN ▼ -11.9% - Lantern Pharma Inc.Sep 29, 2026LTRN ▼ -1.3% - Lantern Pharma Inc.Sep 22, 2026LTRN ▼ -1.3% - Lantern Pharma Inc.Sep 22, 2026LTRN ▼ -1.3% - Lantern Pharma Inc.Sep 22, 2026LTRN SEC Filing Update (04-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 4, 2026$LTRN SEC Filing Update (23-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 23, 2026
View full $LTRN filing history →💬 Comments
Loading comments…
Leave a comment